Quitting Matters: a smoking quit program for people living with HIV
Official title: Hybrid Trial of a Digital Therapeutic for Smoking Cessation Among Persons Living With HIV
Run by Wake Forest University Health Sciences · NCT06883097 · Data updated 2026-11-12
This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 314 (estimated) |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Locations | 1 site (Winston-Salem, North Carolina) |
| Status | Recruiting |
| Started | August 18, 2025 |
| Main results expected | September 2028 |
| Study ends | September 2028 |
| Registry record updated | September 30, 2026 |
| Trial ID | NCT06883097 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults (18+) living with HIV who smoke daily, want to quit, are currently in HIV care, can use NRT, and own an Android or iOS smartphone.
✕Probably not a fit
People who are pregnant, currently receiving other smoking-cessation treatments, medically ineligible for NRT, not fluent in English, or who cannot use a smartphone are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants who smoke and are receiving HIV care will be randomized to use one of two smartphone smoking-cessation apps for about 24 weeks while receiving nicotine replacement therapy (patches and gum). The trial includes five video-call visits during which staff collect questionnaires, interviews, and breath or saliva samples to measure smoking outcomes. One app is specifically tailored for people with HIV and the other is a general quit app, allowing comparison of effectiveness and implementation barriers. The study also documents feasibility and factors that affect adoption of digital therapeutics in this population.
Why it matters
Potential benefit: If successful, a tailored app plus NRT could increase quit rates among people living with HIV and reduce smoking-related illness in this group.
How similar studies have gone: Digital smoking-cessation apps have shown effectiveness in the general population, but large trials of tailored apps for people with HIV are lacking.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Self-reported daily cigarette smoking over the past 30 days 2. Self-reported HIV status 3. Age 18 or older 4. Desire to quit smoking 5. Willing and medically eligible to use NRT 6. Currently receiving HIV care 7. Currently owning an Android or iOS smartphone Exclusion Criteria: 1. Current acute psychotic episode or unsafe to participate in the study 2. Pregnant or intending to become pregnant in the next 6 months 3. Currently receiving any pharmacological and/or behavioral intervention or counseling for smoking cessation 4. Any medical condition or medication that could compromise subject safety, as determined by the PIs and/or study physician 5. Not able to fluently speak and write in English 6. Hearing, comprehension, visual, speech, or motor limitations that preclude study participation
Where it's running
-
Wake Forest University, Implementation Science
Winston-Salem, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Roger Vilardaga Viera, Ph.D. — Wake Forest University Health Sciences
- Study coordinator: Roger Vilardaga Vierra, Ph.D.
- Email: Roger.Vilardaga@wfusm.edu
- Phone: 336-716-1495
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Communal coping in couples where both partners smoke during a quit attempt
This project tests whether couples who tackle quitting as a team (communal coping) fare better when one partner in a smoking couple tries to quit.
-
Extended tobacco support for people experiencing homelessness
This program tests whether extending tobacco treatment to 6 months with pharmacist counseling, monthly nicotine replacement deliveries, and phone wellness coaching helps adults experiencing homelessness quit smoking compared with a 3-month package.
-
A program to help people quit smoking using CBT and mindfulness audio support
This study is testing if combining text messages for quitting smoking with mindfulness audio support helps people stop smoking better than just using text messages alone.
-
AI Molar Mind to help people quit smoking with oral health feedback
This study will test whether AI Molar Mind, a digital tool that reviews your oral health and gives personalized feedback, can help adults who smoke at least five cigarettes a day quit smoking.
-
Smoking cessation for parents with health navigator support to tackle social needs
We’re testing a program that helps parents quit smoking and also addresses their social challenges to reduce kids’ exposure to secondhand smoke.
-
Optimizing a smoking cessation program for people living with HIV
This study is trying to find the best way to help people living with HIV quit smoking by using a mix of support methods like counseling, mentoring, and text reminders.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.